A Phase II, randomized, active and vehicle controlled, Investigator blind, multi-centre study to evaluate the efficacy, safety and tolerability of topically applied tretinoin formulated with TPM as an anti-acne preparation in human subjects with acne vulgaris.

Trial Profile

A Phase II, randomized, active and vehicle controlled, Investigator blind, multi-centre study to evaluate the efficacy, safety and tolerability of topically applied tretinoin formulated with TPM as an anti-acne preparation in human subjects with acne vulgaris.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Tretinoin (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Phosphagenics
  • Most Recent Events

    • 19 Nov 2014 New source identified and integrated: Australian New Zealand Clinical Trials Registry record.
    • 08 Oct 2014 Status changed from active, no longer recruiting to completed, according to a Phosphagenics media release.
    • 07 Oct 2014 Primary endpoints (change in total acne lesion count, and success rate on the Investigators Global Assessment) have not been met, but the trial was not powered for significance, according to a Phosphagenics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top